Autophagy activator, hyaluronic acid production promoter, and antioxidant

The lactic acid fermented product from tea tree-derived materials with specific bacteria activates autophagy, promotes hyaluronic acid production, and shows antioxidant properties, addressing the need for effective autophagy activation and skin health improvement.

WO2024247867A1PCT designated stage expired Publication Date: 2024-12-05AUTOPHAGYGO INC
View PDF 7 Cites 0 Cited by

Patent Information

Application Number
PCT/JP2024/018958
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2023-05-29
Filing Date
2024-05-23
Publication Date
2024-12-05

AI Technical Summary

Technical Problem

Current technologies lack effective autophagy activators that also promote hyaluronic acid production and exhibit antioxidant properties, which are desirable for addressing neurodegenerative diseases and improving skin health.

Method used

A lactic acid fermented product obtained by fermenting tea tree-derived raw materials, such as tea leaves, with lactic acid bacteria like Lactobacillus pentosus and Lactobacillus plantarum, which serves as an autophagy activator, hyaluronic acid production promoter, and antioxidant.

Benefits of technology

The lactic acid fermented product enhances autophagy activity, increases hyaluronic acid production, and demonstrates antioxidant effects, potentially benefiting in neurodegenerative disease management and skin health improvement.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure JP2024018958_05122024_PF_FP_ABST
    Figure JP2024018958_05122024_PF_FP_ABST
Patent Text Reader

Abstract

Provided is a new autophagy activator. Provided are an autophagy activator, a hyaluronic acid production promoter, and an antioxidant that contain a lactic acid fermentation product obtained by fermenting a Camellia-sinensis-derived raw material using lactic acid bacteria.
Need to check novelty before this filing date? Find Prior Art

Description

Autophagy activator, hyaluronic acid production promoter and antioxidant

[0001] The present disclosure relates to an autophagy activator, a hyaluronic acid production promoter, and an antioxidant.

[0002] Autophagy is one of the intracellular protein degradation systems found in eukaryotes. Specifically, an isolation membrane appears within the cell and surrounds a portion of the cytoplasm or intracellular organelles, forming an autophagosome. Lysosomes then fuse with the autophagosome to form an autolysosome. In the autolysosome, hydrolytic enzymes present in the lysosome degrade the proteins and other substances contained therein. This mechanism is expected to be effective in removing aggregated proteins in neurodegenerative diseases such as Parkinson's disease (Patent Document 1). Thus, the usefulness of the physiological functions of autophagy is being discovered, and the development of substances with autophagy activity is desired.

[0003] Japanese Patent Application Laid-Open No. 2019-94303

[0004] An object of the present disclosure is to provide a new autophagy activator.

[0005] The present inventors have conducted various studies and found that a specific material has excellent autophagy activity. Furthermore, the present inventors have also found that this specific material has hyaluronic acid production-promoting activity and antioxidant activity, and have thus completed the present disclosure.

[0006] Disclosure (1) is an autophagy activator comprising a lactic acid fermentation product (lactic acid bacteria fermentation product) obtained by fermenting a tea plant-derived raw material with lactic acid bacteria. Disclosure (2) is the autophagy activator of Disclosure (1), in which the lactic acid fermentation product is obtained by macerating the boiled and / or steamed tea plant-derived raw material with the lactic acid bacteria and subjecting it to lactic acid fermentation. Disclosure (3) is the autophagy activator of Disclosure (1) or (2), in which the tea plant-derived raw material is tea leaves. Disclosure (4) is the autophagy activator of any one of Disclosures (1) to (3), in which the lactic acid bacteria include at least one selected from Lactobacillus pentosus and Lactobacillus plantarum. Disclosure (5) is the autophagy activator according to any one of Disclosures (1) to (4), wherein the lactic acid fermentation product is Awabancha tea. Disclosure (6) is a food, beverage, supplement, cosmetic, pharmaceutical, or quasi-drug containing the autophagy activator according to any one of Disclosures (1) to (5). Disclosure (7) is a cosmetic for improving skin elasticity, improving water retention, preventing wrinkles, anti-aging, or ameliorating aging, containing the autophagy activator according to any one of Disclosures (1) to (5). Disclosure (8) is a supplement for anti-aging, ameliorating aging, or preventing lifestyle-related diseases, containing the autophagy activator according to any one of Disclosures (1) to (5). Disclosure (9) is a hyaluronic acid production promoter containing a lactic acid fermentation product (lactic acid bacteria fermentation product) obtained by fermenting a tea plant-derived material with lactic acid bacteria. The present disclosure (10) is the hyaluronic acid production promoter of the disclosure (9), wherein the lactic acid fermented product is obtained by macerating the boiled and / or steamed tea plant-derived raw material with the lactic acid bacteria and subjecting it to lactic acid fermentation. The present disclosure (11) is the hyaluronic acid production promoter of the disclosure (9) or (10), wherein the tea plant-derived raw material is tea leaves. The present disclosure (12) is the hyaluronic acid production promoter of any one of the disclosures (9) to (11), wherein the lactic acid bacteria include at least one selected from Lactobacillus pentosus and Lactobacillus plantarum.Disclosure (13) is the hyaluronic acid production promoter of any one of Disclosures (9) to (12), wherein the lactic acid fermentation product is Awa Bancha tea. Disclosure (14) is a food, beverage, supplement, cosmetic, pharmaceutical, or quasi-drug containing the hyaluronic acid production promoter of any one of Disclosures (9) to (13). Disclosure (15) is a cosmetic for improving skin elasticity, improving water retention, preventing wrinkles, anti-aging, or ameliorating aging, containing the hyaluronic acid production promoter of any one of Disclosures (9) to (13). Disclosure (16) is a supplement for anti-aging, ameliorating aging, or preventing lifestyle-related diseases, containing the hyaluronic acid production promoter of any one of Disclosures (9) to (13). Disclosure (17) is an antioxidant containing a lactic acid fermentation product (lactic acid bacteria fermentation product) obtained by fermenting a tea plant-derived material with lactic acid bacteria. Disclosure (18) is the antioxidant of Disclosure (17), wherein the lactic acid fermented product is obtained by macerating the boiled and / or steamed tea plant-derived raw material with the lactic acid bacteria and subjecting it to lactic acid fermentation. Disclosure (19) is the antioxidant of Disclosure (17) or (18), wherein the tea plant-derived raw material is tea leaves. Disclosure (20) is the antioxidant of any one of Disclosures (17) to (19), wherein the lactic acid bacteria include at least one selected from Lactobacillus pentosus and Lactobacillus plantarum. Disclosure (21) is the antioxidant of any one of Disclosures (17) to (20), wherein the lactic acid fermented product is Awa Bancha tea. The present disclosure (22) is a food, beverage, supplement, cosmetic, pharmaceutical, or quasi-drug containing any one of the antioxidants of disclosures (17) to (21). The present disclosure (23) is a cosmetic for improving skin elasticity, improving water retention, preventing wrinkles, anti-aging, or ameliorating aging, containing any one of the antioxidants of disclosures (17) to (21). The present disclosure (24) is a supplement for anti-aging, ameliorating aging, or preventing lifestyle-related diseases, containing any one of the antioxidants of disclosures (17) to (21).

[0007] According to the present disclosure, a new autophagy activator can be provided.

[0008] Fig. 1 is a graph showing the fluorescence ratio (relative value when the EGFP amount / mRFP amount of the negative control is set to 1) in HeLa cells when the lactic acid fermentation product of Example 1 was added at various concentrations. Fig. 2 is a graph showing the fluorescence ratio (relative value when the EGFP amount / mRFP amount of the negative control is set to 1) in HeLa cells when the lactic acid fermentation product of Example 2 was added at various concentrations. Fig. 3 is a graph showing the amount of hyaluronic acid (unit: μg / mL) in the culture supernatant of normal human adult dermal fibroblasts when the lactic acid fermentation product of Example 3 was added at various concentrations. Fig. 4 is a graph showing the amount of hyaluronic acid (unit: μg / mL) in the culture supernatant of normal human dermal fibroblasts when the lactic acid fermentation product of Example 3 was added at various concentrations.

[0009] An embodiment of the present disclosure will be described in detail below. However, the present disclosure is not limited to the following embodiment.

[0010] In this specification, when multiple upper limit values ​​and multiple lower limit values ​​are separately described, it is assumed that all numerical ranges that can be set by freely combining these upper limit values ​​and lower limit values ​​are described.

[0011] (Autophagy activator) As used herein, "autophagy" refers to a system in which intracellular organelles and proteins are degraded via autophagosome formation within cells. Furthermore, "autophagy is activated" refers to a state in which the intracellular protein recycling mechanism is activated by the induction or promotion of autophagy within cells. Specifically, "autophagy is activated" refers to a state in which at least one of the following processes is induced or promoted: isolation membrane formation, isolation membrane elongation, autophagosome formation, and fusion of autophagosomes with lysosomes.

[0012] Autophagy activity can be confirmed by conventionally known methods for measuring autophagy activity. Examples of such methods include detecting autophagy marker proteins. Examples of autophagy marker proteins include rat microtubule-associated protein 1 light chain 3 (LC3). LC3 exists in two forms: LC3-I and LC3-II. LC3 exists in the cytoplasm as LC3-I, which is converted to the lipid-bound form LC3-II during autophagosome formation and is incorporated into the inner and outer membranes of autophagosomes. Therefore, autophagy activity can be confirmed by detecting LC3-I and LC3-II and measuring the conversion rate to LC3-II (Kabeya Y., Mizushima N., Ueno T., Yamamoto A., Kirisako T., Noda T., Kominami E., Ohsumi Y., Yoshimori T.: LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. The EMBO Journal, 19:5720-5728 (2000)).

[0013] Autophagy activity can also be confirmed by expressing tfLC3, a tandem LC3 fused with two fluorescent proteins (mRFP and EGFP) (Kimura S., Noda T., Yoshimori T.: Dissection of the Autophagosome Maturation Process by a Novel Reporter Protein, Tandem Fluorescent-Tagged LC3. Autophagy 3:452-460 (2007)). This method demonstrates that EGFP disappears in the (auto)lysosomal environment, and a lower EGFP / mRFP ratio in cells indicates more active autophagy. Fluorescence levels in cells can be measured using a fluorescence microscope, for example, and calculated using analytical software.

[0014] (Method for Producing Autophagy Activator) The autophagy activator according to this embodiment includes a lactic acid fermentation product obtained by fermenting a tea plant-derived raw material with lactic acid bacteria. This will be described in detail below.

[0015] First, the term "tea plant-derived raw material" is not particularly limited as long as it is a part of the tea plant, and is a concept that includes, for example, at least one part selected from tea leaves, stems, buds, and roots, as well as processed products thereof. Here, "processing" includes, for example, processing such as rubbing, drying, heat treatment (baking, boiling, steaming, frying, etc.), crushing (including grinding), and extraction. These processes may be repeated multiple times, or different processes may be combined. Furthermore, as long as the tea plant-derived raw material is the main raw material, other plants (e.g., mugwort, Houttuynia cordata, vegetables, fruits) may be used as secondary raw materials.

[0016] The manufacturing method for autophagy activators involves fermenting the tea plant-derived raw materials (plus other auxiliary ingredients) with lactic acid bacteria. For example, "post-fermented tea," which involves microbial fermentation during the manufacturing process, is a well-known example of this, Awa Bancha from Tokushima. According to "Research on Microorganisms in Awa Bancha, a Post-Fermented Tea Produced in Tokushima Prefecture, by Koyama Shota et al.", the traditional manufacturing method for Awa Bancha is as follows: First, in early summer, all green leaves are squeezed from the tea plant branches using specialized equipment. Then, in a kettle, water approximately 10 times the volume of the tea leaves is added and simmered for several minutes to 10 minutes. The tea leaves are then separated from the simmering liquid and rolled for several minutes in a rolling machine used for green tea production. Then, the tea leaves are placed in a tub, pressing down from above. A lid or equivalent is placed on top, and stones of the same weight as the tea leaves are piled on top. The tea leaf simmering liquid is then poured into the tub to a depth of approximately 10 cm above the inner kettle. During this process, a moderate fermented odor wafts through the tub. After fermentation, the tea leaves are loosened and thoroughly dried in the sun on a straw mat for one to several days. A current example of a manufacturing method for Awa Bancha involves harvesting the tea leaves from Sencha green tea plants after they have grown large enough to reach early summer, boiling them in hot water, rolling them, and immersing them in a tub for 2 to 3 weeks to ferment, and then drying them to finish the tea. In recent years, mechanical clippers have been used for harvesting, and dryers and other devices are used for finishing. The traditional and current manufacturing methods for Awa Bancha described above are merely examples, and do not limit the scope of the autophagy activator disclosed herein.

[0017] In this case, the lactic acid bacteria used for fermentation are not particularly limited, but preferably include at least one selected from Lactobacillus pentosus and Lactobacillus plantarum.

[0018] (Method of Using Autophagy Activator) The autophagy activator according to the present embodiment activates the intracellular protein recycling mechanism and can therefore contribute to maintaining cellular homeostasis. Therefore, the autophagy activator according to the present embodiment can be used as a food, beverage, supplement, cosmetic, pharmaceutical, or quasi-drug for humans or animals, or can be incorporated into a food, beverage, supplement, cosmetic, pharmaceutical, or quasi-drug.

[0019] When the autophagy activator according to the present invention is used as a supplement, pharmaceutical, or in a combination, the supplement may be administered in any dosage form, such as oral administration in the form of tablets, capsules, granules, powders, and syrups, as well as parenteral administration in the form of injections, suppositories, transdermal agents, and topical preparations, with oral administration being preferred.

[0020] When the autophagy activator according to this embodiment is incorporated into foods, supplements, cosmetics, etc., the amount of the dried extract in the formulation is 0.001% by mass to 5% by mass, preferably 0.001% by mass to 1% by mass, and more preferably 0.01% by mass to 1% by mass, based on the total mass of the formulation. In this case, any pharmaceutically acceptable component may be appropriately incorporated as an ingredient other than the autophagy activator according to this embodiment. Specifically, such optional ingredients may include excipients, binders, fillers, disintegrants, surfactants, lubricants, dispersants, buffers, diluents, preservatives, flavorings, and fragrances.

[0021] (Hyaluronic acid production promoter) The lactic acid fermented product of the present disclosure has been found to have the effect of promoting hyaluronic acid production. Although the mechanism of this action has not been clarified, it is presumed that this is the result of autophagy activation, since the lactic acid fermented product of the present disclosure has excellent autophagy activity and it is known that activation of autophagy promotes hyaluronic acid production. Thus, the lactic acid fermented product of the present disclosure can be used as a hyaluronic acid production promoter. However, the mechanism of action by which the lactic acid fermented product of the present disclosure exerts its effect of promoting hyaluronic acid production is not limited to that via activation of autophagy, and the hyaluronic acid production promoter of the present disclosure is not limited to that which activates autophagy. The hyaluronic acid production promoting effect can be confirmed, for example, by a conventionally known hyaluronic acid measurement method, such as that disclosed in the Examples below. The manufacturing method and use method of the hyaluronic acid production promoter are the same as those of the above-mentioned autophagy activator.

[0022] (Antioxidant) The lactic acid fermented product of the present disclosure has been found to have antioxidant activity. Although the mechanism of this action has not been clarified, it is presumed that this is the result of autophagy activation, given that the lactic acid fermented product of the present disclosure has excellent autophagy activity and that activation of autophagy is known to produce antioxidant activity. Thus, the lactic acid fermented product of the present disclosure can also be used as an antioxidant. However, the mechanism by which the lactic acid fermented product of the present disclosure exerts its antioxidant effect is not limited to activation of autophagy, and the antioxidant of the present disclosure is not limited to one that activates autophagy. The antioxidant activity can be confirmed, for example, by a conventionally known reactive oxygen measurement method, as disclosed in the Examples below. The production method and usage of the antioxidant are similar to those of the autophagy activator described above.

[0023] The present disclosure is not limited to the above-described embodiments, and various modifications such as design changes may be made based on the knowledge of those skilled in the art, and embodiments with such modifications are also included in the scope of the present disclosure.

[0024] Preparation Examples Example 1: Awabancha (Beads): Extract from Crushed Awabancha Tea Leaves Dried Awabancha tea leaves (product name: Awabancha Tea Leaves, manufactured by Ikawa Fermentation Co., Ltd.) were frozen by immersion in liquid nitrogen for 15 minutes and then crushed using a Multi-Beads Shocker (Yasui Kikai Co., Ltd., Multi-beads Shocker MB3000) at 3000 rpm for 15 seconds. The tea leaf powder obtained by freeze-pulverization was suspended in D-PBS at 100 mg / mL, vortexed for 20 seconds, allowed to stand on ice for 10 minutes, and then centrifuged (4°C, 400 G, 5 minutes). The supernatant was filtered through a filter (Merck Millipore, Millex SLHVR33RB Φ0.45 μm, PVDF, 33 mm).

[0025] (Example 2: Awa Bancha (concentrated): Awa Bancha boiled extract) 25 g of the Awa Bancha tea leaves used in Example 1 were boiled in 1 liter of hot water over low heat for 60 minutes, and the resulting liquid (Ikawa Fermentation Co., Ltd.) was filtered through a filter (ADVANTEC, 13HP045AN filter unit Φ0.45 um).

[0026] <<Assessment of Autophagy Activity>> A tfLC3 stable cell line was generated from cervical epithelioid carcinoma HeLa cells (JCRB Cell Bank: JCRB9004) using retroviruses according to the method of Bhargava et al. (Bhargava KH et al.: Structural basis for autophagy inhibition by the human Rubicon-Rab7 complex. Proceedings of the National Academy of Sciences of the United States of America 117:17003-17010 (2020)). The cells were suspended in growth medium (DMEM medium supplemented with 10% FBS and 4 mM L-glutamine (Cat. No. D6546; Sigma-Alddrich)) to a cell density of 25,000 cells / mL, and 100 μL of the suspension was dispensed into each well of a 96-well plate (Cell Carrier 96 Ultra Black 96well, Clear Bottom, with Lid; PerkinElmer). This 96-well plate was placed in a CO2 incubator and cultured at 37°C under 5% CO2 + 95% air conditions for 24 hours.

[0027] Phosphate-buffered saline (PBS; manufactured by Nacalai Tesque) was added as a solvent to each of the solutions according to Examples 1 and 2 to prepare a dilution series of the samples. Each of the obtained sample solutions was added to the cell culture medium in each well to achieve the final concentration shown on the horizontal axis (%) of the figure. The cells were then placed in a CO2 incubator and cultured for 24 hours under conditions of 37°C, 5% CO2 + 95% air. On the other hand, as a negative control, cells cultured in growth medium containing PBS but no sample were cultured in a separate well under the same conditions as above.

[0028] After incubation, the culture medium was removed from each well and the wells were washed twice with phosphate-buffered saline (PBS). Next, PBS containing 4% paraformaldehyde (Nacalai Tesque) containing Hoechst dye (Hoechst 33342; Dojindo Laboratories) was added to each well and the wells were left to stand for 20 minutes to fix the cells.

[0029] The supernatant from each well was removed and the cells were washed twice with PBS. Cells were photographed using a confocal image cytometer (CQ1; Yokogawa Electric Corporation), and image data containing information on the EGFP and mRFP fluorescence intensities were acquired. For EGFP fluorescence intensity measurements, a BP525 / 50 bandpass filter was used, with an excitation wavelength of 488 nm. For mRFP fluorescence intensity measurements, a BP617 / 73 bandpass filter was used, with an excitation wavelength of 561 nm. The ratio of EGFP to mRFP fluorescence intensity (EGFP / mRFP value) was calculated using image analysis software (CellPathfinder; Yokogawa Electric Corporation).

[0030] Figures 1 and 2 show the EGFP / mRFP values ​​obtained using Examples 1 and 2, expressed as relative values ​​when the EGFP / mRFP value of the negative control was set at 1. As can be seen from the figures, when an extract from crushed Awa Bancha tea leaves or a boiled extract of Awa Bancha was added to the culture medium, the EGFP / mRFP values ​​decreased, indicating that autophagy activity was enhanced.

[0031] Preparation Example: Example 3: Awa Bancha (FD Powder): Extract from Ground Awa Bancha Tea Leaves The Awa Bancha tea leaves used in Example 1 were ground using a tabletop mill (Labo Millser LM-PLUS IFM-800, Iwatani Corporation) to produce tea leaf powder. Approximately 10 g of the resulting tea leaf powder was weighed into a beaker, mixed with 10 mL of Milli-Q water, and extracted with 80°C hot water for 3 hours. Diatomaceous earth (Silica 600S, Chuo Silica Co., Ltd.) was added using a body feed in an amount of 30% by weight based on the dry weight of the tea leaves, and then the mixture was subjected to suction filtration using a Buchner funnel and filter paper. The filtered aqueous solution was powdered using a shelf-type FD (freeze-drying) machine and used as a sample for the following evaluation of hyaluronic acid production-promoting activity and antioxidant activity.

[0032] <Evaluation of hyaluronic acid production promoting activity> Samples were added to normal human adult skin fibroblasts, and the effect on the amount of hyaluronic acid contained in the culture supernatant was evaluated by the following method.

[0033] (Cell culture and sample addition) Normal human adult dermal fibroblasts (Kurashiki Boseki Co., Ltd., FC-0024) were subcultured at 37°C under 5% CO2 using DMEM (Nacalai Tesque, Inc., 08490-05) supplemented with 10% FBS (Cytiva, SH30396.03). The cells were plated in a 96-well plate at 3 x 10 4 Cells were seeded at 0.1 mL per well and cultured for 24 hours. The test samples were dissolved in water to a concentration of 10 mg / mL, and added to DMEM at test concentrations of 0 μg / mL (solvent control), 12.5 μg / mL, 25 μg / mL, and 50 μg / mL. The medium was removed from the 96-well plate, and 100 μL of DMEM containing test samples at various concentrations was added to each well. 24 and 48 hours after addition, the culture supernatants were collected and stored at -80°C.

[0034] (Evaluation of hyaluronic acid content) Hyaluronan DuoSet ELISA Kit (R&D systems, DY3614-05) was used to quantify the amount of hyaluronic acid contained in the collected culture supernatant. The absorbance was measured using a plate reader (PerkinElmer, Enspire) according to the product manual, and the amount of hyaluronic acid contained in the sample of unknown concentration was calculated based on a calibration curve created from the absorbance of the dilution series of the sample of known concentration.

[0035] Figure 3 shows the amount of hyaluronic acid in the culture supernatant 24 and 48 hours after changing the medium to that containing the sample (n=3, mean±SD). In Figure 3, the vertical axis represents the amount of hyaluronic acid (unit: μg / mL), and the horizontal axis represents the amount of sample added. 48 hours after the addition of the sample, the sample-added group tended to have a higher amount of hyaluronic acid in the culture supernatant than the solvent control. While no significant difference was observed in the 12.5μg / mL and 25μg / mL added groups after 24 hours, a tendency for hyaluronic acid to increase was observed, similar to that after 48 hours. These results suggest that the addition of the sample to the medium increases hyaluronic acid in the medium, thereby promoting hyaluronic acid production in skin fibroblasts.

[0036] <Antioxidant Activity Evaluation> Using normal human dermal fibroblasts (hereinafter referred to as "NHDF cells"), the inhibitory effect of the test samples on reactive oxygen species generated within the cells was examined. NHDF cells were purchased from Takara Bio Inc. The culture medium used was Fibroblast Growth Medium 2 (Takara Bio Inc.).

[0037] The test samples were dissolved in water to prepare a 50 mg / mL stock test solution. The stock test solution was then diluted with medium to prepare test solutions with test concentrations of 200, 150, and 100 μg / mL. NHDF cells were seeded into 96-well plates and cultured overnight. Test solutions with test samples at concentrations of 200, 150, and 100 μg / mL were then added and cultured at 37°C for 4 hours (final test sample concentrations of 100, 75, and 50 μg / mL). Cultures containing only medium were used as untreated controls and tested in the same manner. After incubation, the cells were washed with 1 vol% buffer solution (Hanks' Balanced Salt Solution GlutaMAX-1 (100x)). 50 μL of CM-H2DCFDA, a reagent that reacts with reactive oxygen species to produce fluorescence, was added at a concentration of 5 μmol / L and incubated at 37°C for 10 minutes. Pyocyanin, an intracellular reactive oxygen generating reagent, was added to a final concentration of 100 μmol / L and incubated at 37°C for 2 hours.

[0038] Using a microplate reader [SpectraMax M2e, Molecular Devices], the fluorescence intensity of the fluorescent substance produced by the reaction of CM-H2DCFDA with the reactive oxygen species generated intracellularly by the action of pyocyanin was measured (excitation wavelength: 493 nm, emission wavelength: 523 nm). The intracellular reactive oxygen species generation rate was calculated using the following formula based on the fluorescence intensity of each test solution relative to the fluorescence intensity of the untreated control. (References: Wolfe, KL. et al.: J. Agric. Food Chem., 56, 8418-8426 (2008); Schwarzer, C. et al.: Free Radic. Biol. Med., 45, 1653-1662 (2008))

[0039] Fluorescence intensity [Sa]: Fluorescence intensity of each test solution (n=3) Fluorescence intensity [CN]mean: Mean fluorescence intensity of untreated control (n=3)

[0040] The intracellular ROS generation rate is shown in Figure 4 and Table 1 (mean ± SD, n = 3). In Figure 4, the vertical axis represents the intracellular ROS generation rate (unit: %), and the horizontal axis represents the amount of sample added. The sample-added group had a lower intracellular ROS generation rate than the untreated control, and there was a tendency for the intracellular ROS generation rate to decrease in a sample concentration-dependent manner. These results suggest that adding the sample to the medium reduces the intracellular ROS generation rate, i.e., suppresses the generation of ROS in cells.

[0041] CROSS-REFERENCE TO RELATED APPLICATIONS

[0042] This application claims priority based on Japanese Patent Application No. 2023-088180, filed with the Japan Patent Office on May 29, 2023, the entire disclosure of which is incorporated herein by reference in its entirety.

Claims

1. An autophagy activator containing a lactic acid fermentation product made by fermenting tea plant-derived ingredients with lactic acid bacteria.

2. The autophagy activator according to claim 1, wherein the lactic acid fermented product is obtained by soaking the boiled and / or steamed tea plant-derived raw material together with the lactic acid bacteria and allowing it to ferment with lactic acid.

3. The autophagy activator according to claim 1, wherein the tea plant-derived raw material is tea leaves.

4. The autophagy activator according to claim 1, wherein the lactic acid bacteria includes at least one selected from the group consisting of Lactobacillus pentosus and Lactobacillus plantarum.

5. The autophagy activator according to claim 1, wherein the lactic acid fermentation product is Awabancha tea.

6. A food, beverage, supplement, cosmetic, pharmaceutical or quasi-drug comprising the autophagy activator according to any one of claims 1 to 5.

7. A cosmetic product for improving skin elasticity, improving water retention, preventing wrinkles, anti-aging or improving aging, comprising the autophagy activator according to any one of claims 1 to 5.

8. A supplement for anti-aging, improving aging, or preventing lifestyle-related diseases, comprising the autophagy activator according to any one of claims 1 to 5.

9. A hyaluronic acid production promoter containing a lactic acid fermentation product obtained by fermenting tea plant-derived raw materials with lactic acid bacteria.

10. The hyaluronic acid production promoter described in claim 9, wherein the lactic acid fermentation product is obtained by soaking the boiled and / or steamed tea plant-derived raw material together with the lactic acid bacteria and allowing it to ferment with lactic acid.

11. The hyaluronic acid production promoter according to claim 9, wherein the tea plant-derived raw material is tea leaves.

12. The hyaluronic acid production promoter according to claim 9, wherein the lactic acid bacteria includes at least one selected from Lactobacillus pentosus and Lactobacillus plantarum.

13. The hyaluronic acid production promoter according to claim 9, wherein the lactic acid fermentation product is Awabancha tea.

14. A food, beverage, supplement, cosmetic, pharmaceutical or quasi-drug comprising the hyaluronic acid production promoter according to any one of claims 9 to 13.

15. A cosmetic product for improving skin elasticity, improving water retention, preventing wrinkles, anti-aging or improving aging, comprising the hyaluronic acid production promoter according to any one of claims 9 to 13.

16. A supplement for anti-aging, improving aging, or preventing lifestyle-related diseases, comprising the hyaluronic acid production promoter according to any one of claims 9 to 13.

17. An antioxidant containing a lactic acid fermentation product obtained by fermenting tea plant-derived materials with lactic acid bacteria.

18. The antioxidant according to claim 17, wherein the lactic acid fermented product is obtained by soaking the boiled and / or steamed tea plant-derived raw material together with the lactic acid bacteria and allowing it to ferment with lactic acid.

19. The antioxidant according to claim 17, wherein the tea plant-derived raw material is tea leaves.

20. The antioxidant according to claim 17, wherein the lactic acid bacteria includes at least one selected from Lactobacillus pentosus and Lactobacillus plantarum.

21. The antioxidant according to claim 17, wherein the lactic acid fermentation product is Awabancha tea.

22. A food, beverage, supplement, cosmetic, pharmaceutical or quasi-drug comprising the antioxidant according to any one of claims 17 to 21.

23. A cosmetic product for improving skin elasticity, improving water retention, preventing wrinkles, anti-aging or improving aging, comprising the antioxidant according to any one of claims 17 to 21.

24. A supplement for anti-aging, improving aging, or preventing lifestyle-related diseases, comprising the antioxidant according to any one of claims 17 to 21.

Citation Information

Patent Citations

  • Oil-in-water sunscreen cosmetics and method for producing the same

    JP2019094303A

  • Apparatus for molding film

    JP2023088180A

  • METHOD FOR PRODUCING MATERIAL RICH IN gamma-AMINOBUTYRIC ACID HAVING SWEET FLORAL AROMA AND MATERIAL RICH IN gamma- AMINOBUTYRIC ACID HAVING SWEET FLORAL AROMA, PRODUCED BY THE METHOD

    JP2003333990A

  • Method for producing gallic acid and method for producing fermented tea, as well as lactic acid bacteria, lactic acid bacteria compositions, tea fermented products, and foods and drinks

    JP2020018294A

  • Fermented tea composition for controlling intestinal function and method of producing the same

    JP2021180619A